OrbiMed Global Healthcare Fund, L.P. — Form D/A
OrbiMed Global Healthcare Fund, L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2021-07-16. $113.3M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2021-07-16
- Form: D/A
- Accession: 0000902664-21-003544
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $113.3M
- Investors: 10
- Date of first sale: 2014-07-01
- Security types: equity, fund interests
- SEC file number: 021-220964
Issuer
- Name: OrbiMed Global Healthcare Fund, L.P.
- CIK: 0001613540
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK, NY, 10022
- Phone: 212-739-6400
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| David Scotland Bonita | Executive Officer | New York, NY |
| Sven H Borho | Executive Officer | New York, NY |
| Carl L Gordon | Executive Officer | Stamford, CT |
| Geoffrey C Hsu | Executive Officer | New York, NY |
| W. Carter Neild | Executive Officer | NEW YORK, NY |
| - OrbiMed Advisors LLC | Executive Officer | New York, NY |
| - OrbiMed Global Healthcare GP LLC | Executive Officer | New York, NY |
| Jonathan T Silverstein | Executive Officer | New York, NY |
| C. Scotland Stevens | Executive Officer | New York, NY |
| - OrbiMed Advisors LLC | Promoter | New York, NY |
| Samuel D Isaly | Executive Officer | New York, NY |
Other filings by this issuer (7)
More